In breast cancer, LOXL4, LOX, and LOXL2, which are expressed in a hypoxia-inducible factor 1-dependent manner, recruit bone marrow-derived cells and facilitate colonization of the lungs [19]. Here, LOX is linked to breast carcinoma.